Mark Davies
Presidente presso NEUROTECH INTERNATIONAL LIMITED
Profilo
Mark Hamlin Davies is the founder of Cygnet Capital Pty Ltd.
(Investment Management), which was founded in 2003.
He held the title of General Manager at the firm.
Mr. Davies is also the founder of Cygnet Capital Pty Ltd.,1861 Capital Pty Ltd...
Mr. Davies's current job is Non-Executive Chairman at Neurotech International Ltd.
since 2019.
He is also the Chairman at Tryptamine Therapeutics Ltd.
Mr. Davies's former job was Non-Executive Chairman at Exopharm Ltd.
Mr. Davies obtained his undergraduate degree from The University of Western Australia.
Posizioni attive di Mark Davies
| Società | Posizione | Inizio |
|---|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Presidente | 16/08/2022 |
1861 Capital Pty Ltd.
 1861 Capital Pty Ltd. Financial ConglomeratesFinance 1861 Capital Pty Ltd. provides investment services. The private company is based in Dalkeith, Australia. The Australian company was founded by Mark Davies. Mark Davies has been the CEO since incorporation. | Fondatore | - |
Precedenti posizioni note di Mark Davies
| Società | Posizione | Fine |
|---|---|---|
Cygnet Capital Pty Ltd. (Investment Management)
 Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital Pty Ltd. (Investment Management) (Cygnet Capital-IM) is the investment management division of Cygnet Capital Pty Ltd., a brokerage firm headquartered in Melbourne, Australia. The firm was co-founded by Darien Jagger and Jonathan Rosham in 2003. Cygnet Capital-IM identifies and structures investment opportunities in emerging companies. | Fondatore | - |
| EXOPHARM | Presidente | - |
Cygnet Capital Pty Ltd.
 Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Cygnet Capital Pty Ltd. is an investment firm that has been identifying and structuring investment opportunities in emerging companies for over twenty years. The private company is based in Melbourne, Australia. The Australian company engages founders with focus, talent, and hunger. and has subsidiaries in Australia. The company was founded in 2003 by Darien Jagger, Jonathan Rosham, Mark Davies. Jonathan Rosham has been the CEO since 2003. | Fondatore | - |
Formazione di Mark Davies
| The University of Western Australia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Cygnet Capital Pty Ltd.
Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Cygnet Capital Pty Ltd. is an investment firm that has been identifying and structuring investment opportunities in emerging companies for over twenty years. The private company is based in Melbourne, Australia. The Australian company engages founders with focus, talent, and hunger. and has subsidiaries in Australia. The company was founded in 2003 by Darien Jagger, Jonathan Rosham, Mark Davies. Jonathan Rosham has been the CEO since 2003. | Finance |
Cygnet Capital Pty Ltd. (Investment Management)
Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital Pty Ltd. (Investment Management) (Cygnet Capital-IM) is the investment management division of Cygnet Capital Pty Ltd., a brokerage firm headquartered in Melbourne, Australia. The firm was co-founded by Darien Jagger and Jonathan Rosham in 2003. Cygnet Capital-IM identifies and structures investment opportunities in emerging companies. | Finance |
1861 Capital Pty Ltd.
1861 Capital Pty Ltd. Financial ConglomeratesFinance 1861 Capital Pty Ltd. provides investment services. The private company is based in Dalkeith, Australia. The Australian company was founded by Mark Davies. Mark Davies has been the CEO since incorporation. | Finance |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
- Borsa valori
- Insiders
- Mark Davies
